ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg is administered in the office setting using a specially designed applicator

The ILUVIEN CONTINUOUS MICRODOSING™ Delivery implant is inserted into the vitreous cavity via a 25-gauge needle

  • Each implant contains 0.19 mg fluocinolone acetonide (FAc)
  • Engineered to provide a submicrogram release at an initial rate of 0.25 µg/day lasting 36 months1
  • Each sterile, single-use, preloaded custom applicator is packaged in a sealed tray that should be stored at room temperature between 59oF and 86oF
Watch the ILUVIEN CONTINUOUS MICRODOSING™ Delivery System administration video.

For complete information regarding ILUVIEN administration, please refer to:

Full Prescribing Information (PDF)

Administration Guide (PDF)